WCM Investment Management
MDGL icon

WCM Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

WCM Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Sell
22,985
-575
-2% -$295K 0.02% 142
2026
Q1 		$11.9M Buy
23,560
+6,306
+37% +$3.01M 0.03% 133
2025
Q4 		$10.1M Sell
17,254
-1,037
-6% -$530K 0.02% 150
2025
Q3 		$8.1M Buy
+18,291
New +$6.82M 0.02% 151

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management's MDGL Position: Q2 2026 in Review

WCM Investment Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.4% in Q2 2026, selling an estimated $295K and leaving 22,985 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #142.

WCM Investment Management first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • WCM Investment Management held 22,985 shares of Madrigal Pharmaceuticals worth $12.1M as of Q2 2026.
  • WCM Investment Management sold 575 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $295K.
  • Madrigal Pharmaceuticals made up 0.02% of WCM Investment Management's portfolio in Q2 2026, its #142 holding.
  • WCM Investment Management first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.